May 2009

Investigators in a new study find little difference between cognitive screenings and standard care in limiting emergency department visits from nursing home residents.

Reporting on new research and emerging trends in breast and liver cancer.

Key findings from the 2008 ASCO Breast Cancer conference; updates on goserelin, capecitabine, docetaxel & lapatinib.

Cutting-edge treatments for hepatocellular carcinoma, including contrast-enhanced ultrasound, combined CRT/TACE, sorafenib, & LCCRT for patients with PVT.

A pivotal phase III study is currently underway to evaluate the efficacy and safety of Novartis’ novel anti-cancer compound ASA404 in patients with non–small cell lung cancer (NSCLC).

During the 2006–2007 season, influenza circulated at epidemic levels for about 14 weeks and peaked during February, the month most frequently associated with peak activity over the past 31 influenza seasons.

Breast cancer in general is not openly discussed in Malaysia, but this may be changing.

Breast Cancer Network of Strength is always looking for different ways to meet the needs of women with breast cancer.

The purpose of this Priority Report is to raise awareness of metastatic breast cancer.

New Research Presented at ASCO Highlights Advantages of Pegfilgrastim in Patients Receiving Chemotherapy for a Wide Variety of Solid Tumors and Hematologic Malignancies

One of the most uncomfortable consequences of anticancer therapy is the development of oral mucositis.